LexDanaLexDanabeta
Inventor

TOSHITADA TAKEMORI

Inventor
JP

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
12,497,461Human NTCP-binding antibody capable of inhibiting infection of hepatitis B virus (HBV) to human hepatocytes202511,339,224Anti-Eva1 protein antibody202211,261,244Antibody against human TGF-b LAP degradate, and use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to RIKEN (2)· patent assignee history
2022Patents assigned to SYSMEX CORP (1)· patent assignee history
2022Patents assigned to THE JIKEI UNIV (1)· patent assignee history
2022Patents assigned to UNIV HOKKAIDO NAT UNIV CORP (1)· patent assignee history
2022–2025Based in JP· patent location history
2025Patents assigned to HIROSHIMA INST OF LIFE SCIENCES (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIKEN22022–2025
HIROSHIMA INST OF LIFE SCIENCES12025
SYSMEX CORP12022
THE JIKEI UNIV12022
UNIV HOKKAIDO NAT UNIV CORP12022
Locations
LocationPatentsSpan
JP32022–2025